Sex,NCRAS_Draw,Stage,Age_lower,variable,t,median_CrI,median,CrI_temp,2.5%,97.5%,CrI,Age_string,ex
Female,allexcprostate,I,65,rmst,32,15.7 (15.67 to 15.74),15.7,15.67 to 15.74,15.67,15.74,(15.67 to 15.74),65 years at diagnosis,20.823043823242188
Female,allexcprostate,II,65,rmst,32,13.82 (13.73 to 13.92),13.82,13.73 to 13.92,13.73,13.92,(13.73 to 13.92),65 years at diagnosis,20.823043823242188
Female,allexcprostate,III,65,rmst,32,8.89 (8.79 to 8.99),8.89,8.79 to 8.99,8.79,8.99,(8.79 to 8.99),65 years at diagnosis,20.823043823242188
Female,allexcprostate,IV,65,rmst,32,3.19 (3.11 to 3.26),3.19,3.11 to 3.26,3.11,3.26,(3.11 to 3.26),65 years at diagnosis,20.823043823242188
Male,allexcprostate,I,65,rmst,32,13.24 (13.15 to 13.33),13.24,13.15 to 13.33,13.15,13.33,(13.15 to 13.33),65 years at diagnosis,18.201061248779297
Male,allexcprostate,II,65,rmst,32,9.41 (9.25 to 9.55),9.41,9.25 to 9.55,9.25,9.55,(9.25 to 9.55),65 years at diagnosis,18.201061248779297
Male,allexcprostate,III,65,rmst,32,6.69 (6.58 to 6.81),6.69,6.58 to 6.81,6.58,6.81,(6.58 to 6.81),65 years at diagnosis,18.201061248779297
Male,allexcprostate,IV,65,rmst,32,2.92 (2.86 to 2.97),2.92,2.86 to 2.97,2.86,2.97,(2.86 to 2.97),65 years at diagnosis,18.201061248779297
